JP2005504098A - 過剰増殖性障害の処置に有用なピラゾール誘導体 - Google Patents

過剰増殖性障害の処置に有用なピラゾール誘導体 Download PDF

Info

Publication number
JP2005504098A
JP2005504098A JP2003530665A JP2003530665A JP2005504098A JP 2005504098 A JP2005504098 A JP 2005504098A JP 2003530665 A JP2003530665 A JP 2003530665A JP 2003530665 A JP2003530665 A JP 2003530665A JP 2005504098 A JP2005504098 A JP 2005504098A
Authority
JP
Japan
Prior art keywords
alkyl
substituted
substituents selected
phenyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003530665A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504098A5 (OSRAM
Inventor
キーレ，ウダイ
ツアング，チエンツイー
クルーンダー，ハロルド・シー・イー
ムゲ，インゴ
ホング，ツエンシー
シヤオ，ジヤンシン
ビフアルコ，ニール
トレイル，パメラ・エイ
デユマ，ジヤツク
ラボワ，リコ・シー
リウ，シアオ−ガオ
アガーワル，ベーナ
バーマ，シヤラド・ケイ
ワング，レイ
Original Assignee
バイエル・フアーマシユーチカルズ・コーポレーシヨン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイエル・フアーマシユーチカルズ・コーポレーシヨン filed Critical バイエル・フアーマシユーチカルズ・コーポレーシヨン
Publication of JP2005504098A publication Critical patent/JP2005504098A/ja
Publication of JP2005504098A5 publication Critical patent/JP2005504098A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2003530665A 2001-09-25 2002-09-20 過剰増殖性障害の処置に有用なピラゾール誘導体 Withdrawn JP2005504098A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32457301P 2001-09-25 2001-09-25
PCT/US2002/029958 WO2003027074A1 (en) 2001-09-25 2002-09-20 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders

Publications (2)

Publication Number Publication Date
JP2005504098A true JP2005504098A (ja) 2005-02-10
JP2005504098A5 JP2005504098A5 (OSRAM) 2006-01-05

Family

ID=23264199

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003530665A Withdrawn JP2005504098A (ja) 2001-09-25 2002-09-20 過剰増殖性障害の処置に有用なピラゾール誘導体

Country Status (5)

Country Link
US (1) US20040180891A1 (OSRAM)
EP (1) EP1432689A1 (OSRAM)
JP (1) JP2005504098A (OSRAM)
CA (1) CA2461128A1 (OSRAM)
WO (1) WO2003027074A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513361A (ja) * 2006-12-22 2010-04-30 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ ヘテロシクリル基によって置換されたエチルアミノフェニル誘導体、その調製方法、および医薬としての使用方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557711B (zh) * 2014-12-26 2017-12-15 南通大学 含fts结构的吡唑肟类化合物的制备和应用
CN116768797A (zh) * 2022-03-16 2023-09-19 成都苑东生物制药股份有限公司 一种吡唑类衍生物、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2526469A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 1-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4117145A (en) * 1975-06-13 1978-09-26 Bayer Aktiengesellschaft 1-substituted pyrazoles
NL8201321A (nl) * 1981-04-07 1982-11-01 Bayer Ag Werkwijze voor de behandeling van metastase en de groei van tumorcellen.
DE3312581A1 (de) * 1983-04-08 1984-10-11 Bayer Ag, 5090 Leverkusen Verwendung von pyrazolonderivaten bei der bekaempfung des wachstums von tumorzellen und der metastasenbildung, arzneimittel hierfuer und verfahren zu deren herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513361A (ja) * 2006-12-22 2010-04-30 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ ヘテロシクリル基によって置換されたエチルアミノフェニル誘導体、その調製方法、および医薬としての使用方法

Also Published As

Publication number Publication date
CA2461128A1 (en) 2003-04-03
EP1432689A1 (en) 2004-06-30
US20040180891A1 (en) 2004-09-16
WO2003027074A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
AU2022259742B2 (en) Human plasma kallikrein inhibitors
US10604532B2 (en) Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases
JP7033079B2 (ja) 芳香族スルホンアミド誘導体
CN101765596B (zh) 用于治疗过增生症状和与血管生成有关疾病的缺氧诱导因子(hif)抑制剂
CN102791690B (zh) 作为抗癌药的二取代吡啶衍生物
JP5379690B2 (ja) ５員複素環化合物
WO2006085685A1 (ja) ピラゾール化合物
JP2002500619A (ja) 置換ビフェニルイソオキサゾールスルホンアミド
WO2004046118A2 (en) 2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders
CA2978823A1 (en) Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
PL183008B1 (pl) Nowe związki, pochodne bifenyloizoksazolosulfonamidu i środek farmaceutyczny
TW200416029A (en) Agent for preventing or treating neuropathy
WO2009123316A1 (ja) 複素環誘導体及びその用途
PL203771B1 (pl) Pochodna bifenylosulfonamidu jako dualny antagonista receptorów angiotensyny i endoteliny, sposób jej wytwarzania i jej zastosowanie oraz pochodna bifenylu i pochodna benzenu
WO2001060819A1 (en) Novel isoxazole and thiazole compounds and use thereof as drugs
HRP20040874A2 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
EP2346831B1 (en) Heteroaryl diamide compounds useful as mmp-13 inhibitors
KR20040013557A (ko) 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
TW201602089A (zh) 多環性ｈｅｒｇ活化劑
JP2005504098A (ja) 過剰増殖性障害の処置に有用なピラゾール誘導体
WO2004094376A1 (en) Hydroxamic acids useful in the treatment of hyper-proliferative disorders
TWI901639B (zh) 雜環glp-1促效劑
KR100576343B1 (ko) 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
KR100576339B1 (ko) 피리다진-4-온 유도체, 그 제조방법 및 약제학적 조성물
HK40079811A (en) Aromatic sulfonamide derivatives

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050914

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050914

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20070711